Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
AIDS-Related Plasmablastic Lymphoma
AIDS Malignancy Consortiumgene_therapyPhase 1/2Active
CCC
54/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 40/ 100
- Competitive Position
- 95/ 100
Competitive context
23 Active assets in the AIDS-Related Plasmablastic Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE National Cancer Institute (NCI) | Phase 2 | BB |
PREDNISONE TABLETS National Cancer Institute (NCI) | Phase 2 | BB |
Inno-206 National Cancer Institute (NCI) | Phase 2 | BB |
(+)-VINCRISTINE National Cancer Institute (NCI) | Phase 2 | BB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 2 | BB |
View all 27 →
Same molecule, other indications
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →